RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Activity
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

146 hedge funds and large institutions have $841M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
-3
Holders Change %
-2.01%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
45
Reduced
45
Closed
15
Calls
$13.2M
Puts
$8.04M
Net Calls
+$5.14M
Net Calls Change
+$53.9M

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
$31.2M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
$7.89M
3
SI
Sofinnova Investments
California
$23.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
$16.1M
5
ECM
ExodusPoint Capital Management
New York
$3.7M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$122M
2
OM
Opaleye Management
Massachusetts
$5.58M
3
Franklin Resources
Franklin Resources
California
$19.3M
4
RCMNY
Rubric Capital Management (New York)
New York
$0
5
Verition Fund Management
Verition Fund Management
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$5.93M -$156K -5,143 -3%
OM
27
Opaleye Management
Massachusetts
$5.58M -$6.78M -223,252 -55%
MB
28
MPM BioImpact
Massachusetts
$5.47M – – –
Millennium Management
29
Millennium Management
New York
$4.63M -$2.62M -86,175 -36%
ECM
30
ExodusPoint Capital Management
New York
$3.7M +$3.25M +106,927 +721%
Nuveen Asset Management
31
Nuveen Asset Management
Illinois
$3.45M +$247K +8,114 +8%
IHAM
32
Integral Health Asset Management
New York
$3.17M +$2.11M +69,369 +198%
Balyasny Asset Management
33
Balyasny Asset Management
Illinois
$2.94M +$2.66M +87,481 +960%
GCM
34
Graham Capital Management
Connecticut
$2.92M +$969K +31,884 +50%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.81M -$862K -28,367 -24%
Bank of America
36
Bank of America
North Carolina
$2.7M +$322K +10,609 +14%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$2.49M +$758K +24,938 +44%
KCM
38
Kennedy Capital Management
Missouri
$2.39M -$27.3K -898 -1%
Jane Street
39
Jane Street
New York
$2.32M +$1.87M +61,622 +418%
Goldman Sachs
40
Goldman Sachs
New York
$2.32M -$945K -31,102 -29%
HWAM
41
Hennion & Walsh Asset Management
New Jersey
$2.02M +$557K +18,333 +38%
Luther King Capital Management (LKCM)
42
Luther King Capital Management (LKCM)
Texas
$1.99M -$91.2K -3,000 -4%
AC
43
AWH Capital
Texas
$1.98M -$304K -10,000 -13%
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.92M – – –
PP
45
PDT Partners
New York
$1.92M +$1.61M +52,907 +511%
Ensign Peak Advisors
46
Ensign Peak Advisors
Utah
$1.91M +$1.26M +41,309 +193%
DFO
47
Duquesne Family Office
New York
$1.79M – – –
HighTower Advisors
48
HighTower Advisors
Illinois
$1.71M +$45.7K +1,500 +3%
TWM
49
Tolleson Wealth Management
Texas
$1.44M – – –
JPMorgan Chase & Co
50
JPMorgan Chase & Co
New York
$1.35M +$491K +16,148 +57%
1
2
3 4 5